PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
|Articles|October 7, 2011
Pinewood Healthcare
With over 30 years manufacturing healthcare products in Ireland, Pinewood Healthcare is one of the largest generic companies with a workforce of over 340 people.
Advertisement
With over 30 years manufacturing healthcare products in Ireland, Pinewood Healthcare is one of the largest generic companies with a workforce of over 340 people. We are a widely diversified pharmaceutical group and market our products in over 30 countries across the globe. Pinewood Healthcare also markets and distributes branded generics to retail pharmacies and hospitals throughout Ireland.Pinewood Healthcare can offer contract manufacturing and packaging in the following areas: Oral Liquid and Suspensions, Glass, HDPE, Pet, Sachets, Cream and Ointments, Tubes and tubs (plastic and Aluminium), Non- Penicillin Powders, Glass, HDPE, Sachets.
Our manufacturing site in Tipperary has internationally recognised quality standards- ISO9001 and the CE mark which reflects the high standards maintained in Pinewood, at all times manufacturing in a GMP environment. Continuous investment on a purpose built site has created one of the most sophisticated and state of the art factories of its type in Europe.
Our promise is to offer quality products, competitively priced, delivered on time and backed by individual customer service, technical advice and marketing support.
Advertisement
Related to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
Advertisement
Advertisement